IP Library Granted Patent US 8,101,734
Granted Patent B2
US 8,101,734 · App. 11/400,459 · Granted Jan 24, 2012

Ghrelin binding nucleic acids

Assignee: NOXXON Pharma AG
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,101,734
App. No.
11/400,459
Granted
Jan 24, 2012
Kind
B2
Abstract

The present invention is related to a nucleic acid, preferably binding to ghrelin, whereby the nucleic acid comprises a first stretch Box A, and a second stretch Box B, whereby the first stretch Box A comprises about 25 consecutive nucleotides, the second stretch Box B comprises about six to eight consecutive nucleotides, whereby a 3′-terminal stretch of nucleotides of the first stretch Box A hybridizes with the second stretch Box B, whereby upon hybridization a first double-stranded structure is formed, whereby such first double-stranded structure comprises a bulge.

Claims (11)

1. An isolated nucleic acid having the nucleotide sequence set forth in SEQ ID NO: 39 wherein said isolated nucleic acid binds a ghrelin.

2. A kit for the detection of ghrelin, comprising the nucleic acid according to claim 1 .

3. The nucleic acid of claim 1 , wherein said nucleic acid further comprises a hydroxyethyl starch (HES) moiety, a polyethylene glycol (PEG) moiety or both.

4. The nucleic acid of claim 3 , wherein the molecular weight of said PEG moiety is from 20 to 120 kD.

5. The nucleic acid of claim 3 , wherein the molecular weight of said PEG moiety is from 30 to 80 kD.

6. The nucleic acid of claim 3 , wherein the molecular weight of said PEG moiety is 40 kD.

7. The nucleic acid of claim 3 , wherein the HES moiety has a molecular weight from 10 to 130 kD.

8. The nucleic acid of claim 3 , wherein said HES moiety has a molecular weight from 30 to 80 kD.

9. The nucleic acid of claim 3 , wherein said HES moiety has a molecular weight of 50 kD.

10. The nucleic acid of claim 1 , wherein one or more nucleotides of said nucleic acid are L nucleotides.

11. The nucleic acid of claim 1 , wherein all of the nucleotides of said nucleic acid are L nucleotides.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 10, 2006
From: JAROSCH, FLORIAN; EULBERG, DIRK; MAASCH, CHRISTIAN; HELMLING, STEFFEN; KLUSSMANN, SVEN
To: NOXXON PHARMA AG
Reel/Frame 017908/0367 →
Priority Claims (1)
EP 05007795 · Apr 8, 2005 · regional
Continuity (1)
Related Publication 20060258607A1 · Nov 16, 2006